Australian founder US seed raises in 2026: keep your RDTI

If you're an Australian founder US seed raising in 2026, the default advice to "flip to Delaware before the round" is wrong. Australia's R&D Tax Incentive refunds your corporate tax rate plus 18.5% on eligible R&D for sub-$20M-turnover companies, and a full flip can wipe that out. A US holdco over a preserved Pty Ltd usually keeps both the cash and the cap table.

Most Aussie founders raising US seed in 2026 are told the same thing by their first three advisors: incorporate Delaware now, flip the Pty Ltd up, get it done before you talk to a16z. That advice was built for a 2019 fundraising market and a different US tax code. It costs you real money in 2026.

The Australian R&D Tax Incentive is a refundable offset of your corporate tax rate plus an 18.5% premium for companies with turnover under $20M, per the ATO's 2025 guidance. At the small-company corporate rate, that lands at 43.5% cash back on eligible R&D spend. For a seed-stage AI company burning $1.5M a year on engineers in Sydney, that is a six-figure annual cheque the Australian government writes you.

Flip to Delaware naively and that cheque stops. Here's the structure that keeps it.

The 5-step structure for an Australian startup US fundraise without losing RDTI

Featured-snippet block, deliberately first-scroll. Run this past Australian and US tax counsel before executing.

1. Keep the Pty Ltd as the R&D-performing entity. It must stay an Australian tax resident with R&D activity conducted in Australia. The ATO administers the RDTI to Australian tax residents, and moving primary R&D activities offshore jeopardizes eligibility, per ATO guidance.
2. Incorporate a Delaware C-corp as a holdco. This is the entity US investors invest into. It issues the priced preferred or post-money SAFE.
3. Holdco acquires 100% of the Pty Ltd via share-for-share exchange. Existing Aussie shareholders get equivalent stock in Delaware. Pty Ltd becomes a wholly-owned subsidiary, not a sister company.
4. Sign an inter-company services agreement. US holdco contracts the Pty Ltd to perform R&D under arm's-length transfer pricing. The Pty Ltd recognizes that R&D spend on its books, which is what the RDTI claim is calculated on.
5. Maintain Australian tax residency for the Pty Ltd. Board meetings minuted in Australia, central management and control in Australia, R&D staff employed by the Pty Ltd. Move any of these and you move the residency.

This is what advisors mean when they say "stay-Pty-Ltd-with-US-holdco." The cap table looks 100% American to a US VC. The R&D claim looks 100% Australian to the ATO.

What the Aussie founder US VC market actually looks like in 2026

The opening sentence: top-tier US seed funds are no longer flip-or-die on Australian deals.

Decagon, an AI platform founded outside the US, closed funding from 28 investors including Coatue and Index Ventures. That deal pattern, multi-firm syndicates anchored by tier-1 US capital into a non-US-rooted AI company, is the proof point you cite in your own outreach. It tells the partner you're emailing that their firm's legal team has already done a deal that doesn't require a Delaware-only structure.

Funds with public Aussie track records to lead with:

Don't pitch them as if you're an outlier. The Aussie founder US VC pattern is established; pitch on the wedge, not the passport.

When a full Delaware flip actually does make sense

The opening sentence: flip at Series A or later, or flip at seed only if the round is US-led with a US-resident CEO and minimal Australian R&D headcount.

Three situations where the full flip beats the holdco structure:

• You have no meaningful Australian R&D spend. If your engineering team is already in San Francisco and the Pty Ltd is a shell, the RDTI isn't worth preserving. Flip and simplify.
• Your lead investor's LPA prohibits non-US-domiciled portfolio companies. Some smaller US funds and most US fund-of-funds have this constraint. Ask before you pitch, not after the term sheet.
• You're optimizing for a US acquisition exit in under 24 months. Acquirers will require a Delaware parent at close anyway, and pre-flipping de-risks the deal timeline.

Outside those three, the holdco structure wins on cash preservation and optionality.

The traps that kill the Australian startup Delaware setup

The opening sentence: most botched holdco structures fail the same three ways, all of which are avoidable with a one-day legal review before signing.

• Moving IP ownership to the US holdco. This is the single most common error. The moment your IP assignment paperwork has the Delaware entity as assignee, your Australian R&D claim weakens significantly because the Pty Ltd is no longer developing IP it owns. Keep IP in the Pty Ltd or use a properly priced licensing arrangement.
• Hiring all new engineers under the US entity. Founders default to "US entity, US payroll" for incoming hires after the round closes. Do that and your Australian R&D headcount shrinks every quarter, and so does your claim.
• Letting central management and control drift to the US. If the CEO moves to San Francisco and starts running board meetings from there, the Pty Ltd's tax residency is at risk. Document an Australian-resident director and minute meetings accordingly.

The 2025 US tax landscape has its own moving parts too: Cooley flagged proposed legislation that would permit immediate deduction of certain domestic R&E expenditures for tax years beginning after December 31, 2024. That changes the math on which R&D dollars are best spent in which jurisdiction. Get current advice; don't run on 2023 assumptions.

What to do this week

If you're 60 to 90 days from a US seed raise:

• Get a written RDTI eligibility opinion from your Australian accountant. Confirms what your current claim looks like and what a flip would cost in dollar terms. Most Aussie founders have never seen this number written down.
• Brief a dual-jurisdiction firm. The Wilson Sonsini writeup on the Delaware flip mechanics is a useful primer for the share-exchange basics, but you want an Australian firm (MinterEllison, Allens, Gilbert + Tobin) and a US firm (Cooley, Wilson Sonsini, Gunderson) coordinating. Single-sided counsel misses the cross-border traps.
• Ask each US fund on your target list one question before pitching. "Are you comfortable investing into a Delaware C-corp parent with an Australian operating subsidiary?" A yes saves you weeks. A no tells you to deprioritize.

If you're sending more than 30 of these intro emails to US funds, tools like Causo handle the per-fund personalization and structure-fit research automatically. Below 30, do it manually.

FAQ

Can Australian founders raise from US VCs? Yes, and increasingly without a full Delaware flip. Top-tier US firms like Coatue and Index Ventures are funding non-US-domiciled AI startups via parallel structures, with Decagon as a recent example of a 28-investor round closed under that pattern.

Should Aussie startups flip to Delaware? Not by default at seed. A flip can jeopardize your Australian R&D Tax Incentive eligibility because the ATO administers the program to Australian tax residents conducting R&D in Australia. Most seed-stage Aussie founders should use a US holdco that sits over a preserved Pty Ltd operating company instead.

Does the R&D Tax Incentive survive a Delaware flip? Only if the Pty Ltd remains the R&D-performing entity and stays an Australian tax resident. The moment R&D activity, IP ownership, or tax residency moves to a US parent, the refundable offset of corporate tax rate plus an 18.5% premium stops applying to that work. Get tax counsel before signing any flip docs.

Which US VCs invest in Australian companies? Coatue and Index Ventures have backed AI companies founded outside the US, including Decagon. a16z, Accel, and Benchmark have all historically funded Australian-rooted companies (Canva, Atlassian, Culture Amp). Lead with the funds that have a public track record of accepting non-US parents at seed.